WAYNE, Pa.--(BUSINESS WIRE)--Safeguard Scientifics, Inc. (NYSE:SFE), a holding company that builds value in growth-stage life sciences and technology companies, today announced that it has sold an additional 2.4 million shares of its position in Clarient, Inc. (Nasdaq: CLRT) through a Clarient shelf registration on Form S-3 that was declared effective by the Securities and Exchange Commission on August 20, 2009. Underwriters for the offering – Stephens Inc., Robert W. Baird & Co., Stifel, Nicolaus & Company and Boenning & Scattergood – exercised an option to purchase the additional shares.
